ArticleAvicenna journal of medical biotechnology

Targeted Overexpression of NDRG2 using Survivin Promoter Reduces Viability and Invasiveness of A549 Cell Line.

Maryam Fanian et al.PubMed ↗Full text ↗

No numbers read from the abstract.